Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Goddard

Showing results (111-120 of 161) with videos related to

Pageof 17
Sort By:
Journal of the National Cancer Institute|September 6, 2012
Risk of heart failure in breast cancer patients after anthracycline and trastuzumab treatment: a retrospective cohort studyErin J Aiello Bowles, Robert Wellman, Heather Spencer Feigelson, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|January 13, 2017
Genome sequencing and carrier testing: decisions on categorization and whether to disclose results of carrier testingPatricia Himes, Tia L Kauffman, Kristin R Muessig, et al.
JNCI Cancer Spectrum|February 7, 2020
Cost-Effectiveness of Risk-Stratified Colorectal Cancer Screening Based on Polygenic Risk: Current Status and Future PotentialSteffie K Naber, Suman Kundu, Karen M Kuntz, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 17, 2012
KRAS testing and epidermal growth factor receptor inhibitor treatment for colorectal cancer in community settingsJennifer Webster, Tia L Kauffman, Heather Spencer Feigelson, et al.
Physiological Genomics|December 24, 2009
EDNRA variants associate with smooth muscle mRNA levels, cell proliferation rates, and cystic fibrosis pulmonary disease severityRebecca Darrah, Edward McKone, Clare O'Connor, et al.
Hereditary Cancer in Clinical Practice|June 10, 2022
Literacy-adapted, electronic family history assessment for genetics referral in primary care: patient user insights from qualitative interviewsKathleen F Mittendorf, Hannah S Lewis, Devan M Duenas, et al.
Hereditary Cancer in Clinical Practice|January 1, 2020
Recommended care and care adherence following a diagnosis of Lynch syndrome: a mixed-methods studyKathleen F Mittendorf, Jessica Ezzell Hunter, Jennifer L Schneider, et al.
Clinical Case Reports|November 21, 2018
A case for expanding carrier testing to include actionable X-linked disordersAlan F Rope, Tia L Kauffman, Pat Himes, et al.
Environmental Science & Technology|August 20, 2020
Measuring Environmental Exposure to Enteric Pathogens in Low-Income Settings: Review and Recommendations of an Interdisciplinary Working GroupFrederick G B Goddard, Radu Ban, Dana Boyd Barr, et al.
Cancer Medicine|August 30, 2023
Risk management actions following genetic testing in the Cancer Health Assessments Reaching Many (CHARM) Study: A prospective cohort studyBoya Guo, Sarah Knerr, Tia L Kauffman, et al.
Pageof 17

Showing results (111-120 of 161) with videos related to

Sort By:
Pageof 17
Journal of the National Cancer Institute|September 6, 2012
Risk of heart failure in breast cancer patients after anthracycline and trastuzumab treatment: a retrospective cohort studyErin J Aiello Bowles, Robert Wellman, Heather Spencer Feigelson, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|January 13, 2017
Genome sequencing and carrier testing: decisions on categorization and whether to disclose results of carrier testingPatricia Himes, Tia L Kauffman, Kristin R Muessig, et al.
JNCI Cancer Spectrum|February 7, 2020
Cost-Effectiveness of Risk-Stratified Colorectal Cancer Screening Based on Polygenic Risk: Current Status and Future PotentialSteffie K Naber, Suman Kundu, Karen M Kuntz, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 17, 2012
KRAS testing and epidermal growth factor receptor inhibitor treatment for colorectal cancer in community settingsJennifer Webster, Tia L Kauffman, Heather Spencer Feigelson, et al.
Physiological Genomics|December 24, 2009
EDNRA variants associate with smooth muscle mRNA levels, cell proliferation rates, and cystic fibrosis pulmonary disease severityRebecca Darrah, Edward McKone, Clare O'Connor, et al.
Hereditary Cancer in Clinical Practice|June 10, 2022
Literacy-adapted, electronic family history assessment for genetics referral in primary care: patient user insights from qualitative interviewsKathleen F Mittendorf, Hannah S Lewis, Devan M Duenas, et al.
Hereditary Cancer in Clinical Practice|January 1, 2020
Recommended care and care adherence following a diagnosis of Lynch syndrome: a mixed-methods studyKathleen F Mittendorf, Jessica Ezzell Hunter, Jennifer L Schneider, et al.
Clinical Case Reports|November 21, 2018
A case for expanding carrier testing to include actionable X-linked disordersAlan F Rope, Tia L Kauffman, Pat Himes, et al.
Environmental Science & Technology|August 20, 2020
Measuring Environmental Exposure to Enteric Pathogens in Low-Income Settings: Review and Recommendations of an Interdisciplinary Working GroupFrederick G B Goddard, Radu Ban, Dana Boyd Barr, et al.
Cancer Medicine|August 30, 2023
Risk management actions following genetic testing in the Cancer Health Assessments Reaching Many (CHARM) Study: A prospective cohort studyBoya Guo, Sarah Knerr, Tia L Kauffman, et al.
Pageof 17